LCTX Competitors & Alternatives
Compare Lineage Cell Therapeutics Inc with similar stocks in the same industry
Biotechnology
LCTX
Main Stock$1.16
Tradestie Score
53
Market Cap
$385.92M
Revenue Growth
0.1%
Analyst Upside
+374.1%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.23
|
$308.74M | - | 52 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.18
|
$304.12M | - | 58 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$20.86
|
$297.23M | - | 56 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$32.60
|
$293.03M | - | 54 | Compare |
|
OMER
Omeros Corporation
|
$9.69
|
$281.75M | 8.1 | 58 | Compare |
|
DBVT
DBV Technologies S.A.
|
$14.70
|
$275.54M | - | 50 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.79
|
$275.13M | - | 49 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.09
|
$269.08M | - | 56 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$37.31
|
$256.54M | - | 60 | Compare |
More LCTX Analysis
Data updated: Jul 19, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry